Table 4 The comparison of different prognostic models for PFS.

From: Outcome prediction model for patients with unresectable hepatocellular carcinoma treated with targeted therapy

Model

C-index

AUC at 1 years

AUC at 2 years

AUC at 3 years

TUHP PFS model

0.759

0.82

0.86

0.84

BCLC

0.565

0.55

0.59

0.66

CNLC

0.576

0.58

0.68

0.74

HAP

0.632

0.56

0.59

0.52

PROSASH-II

0.681

0.65

0.63

0.61

  1. PFS progression-free survival, C-index concordance index, AUC area under the curve, TUHP targeted therapy for unresectable hepatocellular prognosis, BCLC Barcelona Clinic Liver Cancer, CNLC Chinese Liver Cancer, HAP Hepatoma Arterial Embolization Prognostic system, PROSASH-II Prediction of Survival in Advanced Sorafenib-Treated Hepatocellular Carcinoma-II
Back to article page